Centene Plunges 39% After Withdrawing Annual Guidance on Weak Enrollment, Rising Medical Costs

Centene Corp. shares plunged nearly 40% after the U.S. health insurer withdrew its 2025 guidance, citing weak marketplace enrollment and surging medical costs, with analysts warning of further earnings downside.